GlobeImmune Inc. announced earnings results for the second quarter ended June 30, 2015. For the quarter, the company announced a net loss of $1.3 million compared to a net loss of $9.2 million for the same period in 2014. Net cash used in operating activities was $4.4 million, compared to $5.9 million for the same period in 2014.

The company's losses have resulted principally from costs incurred in its discovery and development activities.